cohorts I and K got 90 Q8 weeks, and cohort E 60 Q4 weeks
2 patients in K and one in E achieved undetectable HBSAg. It looks like one of the 2 in cohort K started to rebound 28 weeks after stopping tx but hard to tell. If you include this pt then that makes 3 out of 20 at the highest doses (none at lower doses) may have functional cures.
adding their core inhibitor didn't boost responses at all
Market Data 
Markets 
AI
